Cephalon Sues Hetero Over Generic Leukemia Drug
Cephalon Inc. filed suit in Delaware federal court Thursday alleging rival Hetero Labs Ltd.'s plans to manufacture a generic form of its cancer treatment Treanda violated a patent for the drug,...To view the full article, register now.
Already a subscriber? Click here to view full article